Re-I Chin MD, MSCI

Re-I Chin MD, MSCI

TEL: 503-216-2195
FAX: 503-216-2196

Dr. Chin chose a career as a radiation oncologist to utilize state-of-the-art technology to deliver precise treatments, while collaborating closely with the multidisciplinary oncology team to improve the lives of patients with cancer. 

Dr. Chin was trained in Computed Tomography and Magnetic Resonance-Guided Adaptive Radiotherapy (ART) during residency. She also trained in gynecologic high-dose rate brachytherapy used to treat cervical/endometrial cancers. 

Concurrently with her residency training, Dr. Chin completed a Master of Science in Clinical Investigation (MSCI), which will help her bring advances in clinical research to the clinic. 

Dr. Chin likes living in Portland because of the endless greens all around, diverse food options, and beautiful outdoor activities. Outside of work, Dr. Chin enjoys traveling, trying new restaurants, photography, playing badminton, and spending time with her family, dog, and cats.

Other Activities

Member, Alpha Omega Alpha (AOA)

Member, American Board of Radiology (ABR)

Member, Radiological Society of North America (RSNA)

Member, American Society for Radiation Oncology (ASTRO)

Member, American Association for Cancer Research (AACR)

Member, American College of Radiation Oncology (ACRO)


Master of Science in Clinical Investigation (MSCI), Washington University, St. Louis, MO, 2021

Resident Intern, Transitional Year, Mercy Hospital, St. Louis, MO, 2019

Doctor of Medicine, Saint Louis University School of Medicine, ST. Louis, MO, 2018

Bachelor of Arts, Biochemistry, Washington University, St. Louis, MO, 2013


Radiation Oncology – Board Eligible


American Radium Society (ARS) Early Career Oncologist Award, 2021

American College of Radiation Oncology (ACRO) Travel Grant, 2021

American College of Radiation Oncology (ACRO) Resident Seed Grant, 2020-2021

Best of ASTRO Abstract, 2020

Radiological Society of North America (RSNA) Annual Conference Travel Award, 2016

Radiological Society of North America (RSNA) Research Medical Student Grant, 2015

Philip & Lillian Katzman Scholarship, 2014-2018

Florence Moog Scholar; Four-year Full-tuition Merit Scholarship, 2009-2013


Chin RI, Schiff JP, Bommireddy A, Kang KH, Price AT, Green OL, Andruska N, Huang Y, Korenblat K, Parikh PJ, Olsen J, Samson PP, Henke LE, Kim H, Badiyan SN. Clinical Outcomes of Patients with Unresectable Primary Liver Cancer Treated with MR-guided Stereotactic Body Radiation Therapy: A Six-year Experience. Clin Transl Radiat Oncol. 2023.

Chin RI, Schiff JP, Shetty AS, Pedersen KS, Aranha O, Huang Y, Hunt SR, Glasgow SC, Byrnes K, Tan BR, Wise PE, Silveira ML, Smith RK, Suresh R, Byrnes K, Badiyan SN, Henke LE, Mutch MG, Kim H. Circumferential Resection Margin as Predictor of Non-clinical Complete Response in Nonoperative Management of Rectal Cancer. Diseases of the Colon & Rectum. 2023. (PMID: 36876988)

Schiff JP, Price A, Stowe HB, Laugeman E, Chin RI, Hatscher C, Pryser E, Cai B, Hugo GD, Kim H, Badiyan SN, Robinson CG, and Henke LE. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiotherapy and Oncology. 2022. (PMID: 36063981)

Chin RI, Bommireddy A, Fraum TJ, Ludwig DR, Huang Y, Zoberi JE, Garcia-Ramirez JL, Maughan NM, Chapman W, Korenblat K, Henke LE, Kim H, and Badiyan SN. Clinical outcomes of patients with unresectable primary liver cancer treated with yttrium-90 radioembolization with an escalated dose. Advances in Radiation Oncology. 2022. (PMID: 35814852)

Chin RI* (co-first author), Otegbeye EE* (co-first author), Kang KH, Chang SH, McHenry S, Roy A, Chapman WC Jr, Henke LE, Badiyan SN, Pedersen KS, Tan BR, Glasgow SC, Mutch MG, Samson P, Kim H. Cost-effectiveness of total neoadjuvant therapy with short-course radiation therapy for resectable locally advanced rectal cancer. JAMA Network Open. 2022. (PMID: 35103791)

Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ. A Rational Approach to Unilateral Neck Radiation for Head and Neck Cancers in the Era of Immunotherapy. Cancers. 2021. (PMID: 34771432)

Chin RI, Roy A, Pedersen KS, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise P, Silviera ML, Smith RK, Suresh R, Badiyan S, Shetty AS, Henke LE, Mutch MG, Kim H. Clinical Complete Response in Patients with Rectal Adenocarcinoma Treated with Short-Course Radiation Therapy and Nonoperative Management. International Journal of Radiation Oncology, Biology, Physics. 2021. (PMID: 34653579)

Chin RI* (co-first author), Rao YJ* (co-first author), Hwang MY, Spencer CR, Pierro M, DeWees T, Patel P, Gay HA, Daly M, Haughey BH, Nussenbaum B, Adkins DR, Wildes T, Lewis JS, Thorstad WL. Comparison of Unilateral Versus Bilateral Intensity Modulated Radiation for Surgically-treated Squamous Cell Carcinoma of the Palatine Tonsil. Cancer. 2017. (PMID 28881377)

Rao YJ* (co-first author), Chin RI* (co-first author), Hui C, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Markovina S. Improved Survival with Definitive Chemoradiation Compared to Definitive Radiation Alone in Squamous Cell Carcinoma of the Vulva: a Review of the National Cancer Database. Gynecology Oncology. 2017. (PMID: 28662775)

Chin RI, Spencer CR, Dewees T, Hwang MY, Patel P, Sinha P, Gay H, Haughey BH, Nussenbaum B, Adkins D, Lewis JS, Thorstad WL. Re-evaluation of Postoperative Radiation Dose in the Management of HPV+ Oropharyngeal cancer. Head & Neck. 2016. (PMID 27152851)